Viewing StudyNCT04360096



Ignite Creation Date: 2024-05-06 @ 2:36 PM
Last Modification Date: 2024-10-26 @ 1:33 PM
Study NCT ID: NCT04360096
Status: TERMINATED
Last Update Posted: 2023-02-03
First Post: 2020-04-21

Brief Title: Inhaled ZYESAMI Aviptadil Acetate for the Treatment of Severe COVID-19
Sponsor: APR Applied Pharma Research sa
Organization: APR Applied Pharma Research sa

Conditions & Keywords Data

Conditions:
Name
Dyspnea
SARS-CoV 2
COVID
ARDS
ALI
Acute Lung InjuryAcute Respiratory Distress Syndrome ARDS
Keywords:
Name View
Vasoactive Intestinal Polypeptide View
Corona Virus View
VIP View
Aviptadil View